AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PureTech Health plc

Major Shareholding Notification Jun 13, 2017

4932_mrq_2017-06-13_4325c0e5-f27f-407a-b584-6cb6ecee4700.html

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9994H

PureTech Health PLC

13 June 2017

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii PURETECH HEALTH PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached No
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments No
An event changing the breakdown of voting rights No
Other (please specify): No
3. Full name of person(s) subject to the notification obligation: iii Recordati SA Chemical and Pharmaceutical Company
4. Full name of shareholder(s)

(if different from 3.):iv
5. Date of the transaction and date on which the threshold is crossed or reached: v 12 June 2017
6. Date on which issuer notified: 13 June 2017
7. Threshold(s) that is/are crossed or reached: vi, vii Below 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares

if possible using the ISIN CODE
Situation previous to the triggering transaction Resulting situation after the triggering transaction
Number of Shares Number of Voting Rights Number of shares Number of voting rights % of  voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BY2Z0H74 9,554,140 9,554,140 0 0 0 0% 0
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date xiii Exercise/ Conversion Period xiv Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date xvii Exercise/ Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
0 0%
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information: This transfer of voting rights relates to a merger by absorption of Recordati SA Chemical and Pharmaceutical Company into Recordati S.p.A, with Recordati S.p.A as the surviving entity.
14. Contact name: Silvia Signoretti
15. Contact telephone number: +39 02 48787533

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLFJMFTMBABBPR

Talk to a Data Expert

Have a question? We'll get back to you promptly.